InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,865.08
(
-1.41%
)
US TECH 100
19,800.00
(
-2.69%
)
Dow Jones
43,433.46
(
-0.73%
)
Brent Oil
70.97
(
-1.72%
)
Bitcoin
90,535.82
(
3.65%
)

Replies to post #104861 on Biotech Values

Replies to #104861 on Biotech Values
icon url

jq1234

09/23/10 8:04 PM

#104930 RE: jq1234 #104861

NVS CEO Jimenez was on CNBC talking about Gilenya approval today. He emphasized the diversification advantage of NVS, espeically they are the second largest generic drug maker in the world.